TI
CRL icon

Turner Investments’s Charles River Laboratories CRL Stock Holding History

Turner Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-16,960
Closed -$1.02M – 569
2014
Q1 		$1.02M Buy
+16,960
New +$989K 0.03% 457
2013
Q3 		– Sell
-64,380
Closed -$2.64M – 608
2013
Q2 		$2.64M Buy
+64,380
New +$2.76M 0.04% 424

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Turner Investments's CRL Position: Q2 2014 in Review

Turner Investments sold out of Charles River Laboratories (CRL) in Q2 2014, closing a stake of 16,960 shares — an estimated $1.02M sold.

Turner Investments first reported a position in CRL in Q2 2013 and held it in 2 quarters. The position peaked at $2.64M in Q2 2013. 262 funds tracked by Wall St. Rank hold CRL as of Q2 2014.

  • Turner Investments reported no remaining Charles River Laboratories position as of Q2 2014 after selling out during the quarter.
  • Turner Investments sold 16,960 Charles River Laboratories shares in Q2 2014, an estimated $1.02M.
  • Turner Investments first reported a position in Charles River Laboratories in Q2 2013 and held it in 2 quarters.
  • Turner Investments's Charles River Laboratories position peaked at $2.64M in Q2 2013.
  • 262 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2014.

Based on Turner Investments's 13F filing for Q2 2014, filed 11 Aug 2014.